Court Rules FDA Didn’t Apply Double Standard to J&J, Amgen Exclusivity Applications

Drug Industry Daily
A A
A District of Columbia court partially ruled against Amgen in a dispute with the FDA over what the company called inconsistent agency approvals of pediatric exclusivity.

To View This Article:

Login

Subscribe To Drug Industry Daily